NEO
NeoGenomics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$17.38
−0.46%Forward multiples
Based on analyst estimates
- P/E forward
- 63.96x
- P/E 2026E
- 95.07x
- P/E 2027E
- 51.37x
- P/E 2028E
- 37.09x
- P/S forward
- 2.65x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.84x
- Price / sales
- 2.91x
- Price / cash flow
- 101.27x
Enterprise value
- Enterprise value
- $2.5B
- EV / sales
- 3.31x
- EV / EBITDA
- 196.78x
- EV / EBIT
- -38.32x
- Market cap
- $2.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026